


| Key | % Net Assets |
|---|---|
| 5.6% | |
| 4.7% | |
| 4.2% | |
| 3.8% | |
| 81.7% |
| Name | % Net Assets |
|---|---|
| AstraZeneca | 5.6% |
| Royal Bank of Scotland Group | 4.7% |
| Rentokil Initial | 4.2% |
| Morrison Supermarkets | 3.8% |
| Barclays | 3.6% |
| Lloyds Banking Group | 3.3% |
| Vodafone Group | 3.2% |
| Dixons Retail | 3.0% |
| Resolution | 2.9% |
| GlaxoSmithKline | 2.9% |
| Key | % Net Assets |
|---|---|
| 26.60% | |
| 25.20% | |
| 15.80% | |
| 10.10% | |
| 9.80% |
| Date | 20-Aug-2025 |
|---|---|
| NAV | 34,290.00p |
| Currency | GBP |
| Change | -140.00p |
| % | -0.41% |
| YTD change | 4,800.00p |
| YTD % | 16.28% |
| Fund Inception | 05/05/1970 |
|---|---|
| Fund Manager | Kevin Murphy / Nick Kirrage |
| TER | 1.52 (15-Jul-2012) |
| Minimum Investment | |
|---|---|
| Initial | £1000 |
| Additional | n/a |
| Savings | £50 |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | 0.16 |
You are here: research